EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed mice.

Prada PO, Ropelle ER, Mourão RH, de Souza CT, Pauli JR, Cintra DE, Schenka A, Rocco SA, Rittner R, Franchini KG, Vassallo J, Velloso LA, Carvalheira JB, Saad MJ

Open source

DOI
10.2337/db08-0506
Published
2009 Dec
Container
Diabetes
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2337/db08-0506,
  title = {EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed mice.},
  author = {Prada PO and Ropelle ER and Mourão RH and de Souza CT and Pauli JR and Cintra DE and Schenka A and Rocco SA and Rittner R and Franchini KG and Vassallo J and Velloso LA and Carvalheira JB and Saad MJ},
  year = {2009},
  journal = {Diabetes},
  doi = {10.2337/db08-0506},
  url = {https://doi.org/10.2337/db08-0506}
}

RIS

TY  - JOUR
TI  - EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed mice.
AU  - Prada PO
AU  - Ropelle ER
AU  - Mourão RH
AU  - de Souza CT
AU  - Pauli JR
AU  - Cintra DE
AU  - Schenka A
AU  - Rocco SA
AU  - Rittner R
AU  - Franchini KG
AU  - Vassallo J
AU  - Velloso LA
AU  - Carvalheira JB
AU  - Saad MJ
PY  - 2009
JO  - Diabetes
DO  - 10.2337/db08-0506
UR  - https://doi.org/10.2337/db08-0506
ER  - 

APA

PO, P., ER, R., RH, M., CT, D. S., JR, P., DE, C., A, S., SA, R., R, R., KG, F., J, V., LA, V., JB, C., & MJ, S. (2009). EGFR tyrosine kinase inhibitor (PD153035) improves glucose tolerance and insulin action in high-fat diet-fed mice.. Diabetes. https://doi.org/10.2337/db08-0506

Source records